Announcement on Progress in Repurchasing Shares
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
As of the end of May, the company has repurchased a small percentage of its total shares, with a total expenditure reported. The repurchase is part of a strategy to support employee stock ownership and enhance shareholder value.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
Earlier from Shenzhen Chipscreen Biosciences
- Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer Multiple
- Indicative Announcement on Pricing for Shareholders' Inquiry-based Transfer
- Shareholders' Inquiry Transfer Plan
- Announcement on Voluntary Disclosure of Approval of Chiglitazar Sodium for Market Release by the Pharmaceutical Administration Bureau, Macao SAR
- Announcement on Receipt of the "Decision on the Examination of an Invalidity Declaration Request" from the China National Intellectual Property Administration
Later from Shenzhen Chipscreen Biosciences
- Announcement on Follow-up Credit Rating Results of "Chipscreen Convertible Bonds"
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.
Follow Shenzhen Chipscreen Biosciences